A recent study conducted by Dutch researchers revealed that women 30 and over should have DNA-based HPV testing to prevent more cases of cancer.
The five-year study followed 45,000 women and determined that human papillomavirus testing should be considered by women over the age of 30, according to researcher Chris Meijer and his colleagues from the VU University Medical Centre in Amsterdam.
Cases of sexually transmitted HPV are usually naturally cleared by the immune system, but certain strains could lead to cervical cancer.
The new tests are found to be beneficial in detecting not only HPV, but pre-cancerous lesions; this is in contrast to a previous study that showed Pap smears alone were better at detecting the signs of cervical cancer. Two screening rounds involving women between the ages of 29 and 56 were undertaken five years apart, producing these outcomes.
According to the U.S. Centers for Disease Control and Prevention, more than 12,000 women are diagnose with cervical cancer every year.
Considering the evolving understanding of doctors on this subject matter, women over the age of 30 may see life insurance as a way to properly prepare for any unforeseen medical expenses.